| 6001 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
17 |
| 6002 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
25 |
| 6003 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
66 |
| 6004 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
70 |
| 6005 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
8 |
| 6006 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
72 |
| 6007 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
40 |
| 6008 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
22 |
| 6009 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
60 |
| 6010 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
53 |
| 6011 |
Bone Marrow |
Allogeneic |
Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
24 |
| 6012 |
Bone Marrow |
Allogeneic |
Bilineal Leukemia – Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
2 |
| 6013 |
Bone Marrow |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2018 |
Standard Therapy |
Poland |
1 |
| 6014 |
Bone Marrow |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2018 |
Standard Therapy |
Poland |
3 |
| 6015 |
Bone Marrow |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2018 |
Standard Therapy |
Poland |
2 |
| 6016 |
Bone Marrow |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2018 |
Standard Therapy |
Poland |
2 |
| 6017 |
Bone Marrow |
Allogeneic |
Congenital Hypoplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
2 |
| 6018 |
Bone Marrow |
Allogeneic |
Diffuse Large B-Cell Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
68 |
| 6019 |
Bone Marrow |
Allogeneic |
Fanconi Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
3 |
| 6020 |
Bone Marrow |
Allogeneic |
Fanconi Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
3 |
| 6021 |
Bone Marrow |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
31 |
| 6022 |
Bone Marrow |
Allogeneic |
Hurler Syndrome |
Hematology |
2018 |
Standard Therapy |
Poland |
2 |
| 6023 |
Bone Marrow |
Allogeneic |
Juvenile Myelomonocytic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
11 |
| 6024 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2018 |
Standard Therapy |
Poland |
4 |
| 6025 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2018 |
Standard Therapy |
Poland |
12 |
| 6026 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2018 |
Standard Therapy |
Poland |
2 |
| 6027 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2018 |
Standard Therapy |
Poland |
70 |
| 6028 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2018 |
Standard Therapy |
Poland |
4 |
| 6029 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2018 |
Standard Therapy |
Poland |
4 |
| 6030 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2018 |
Standard Therapy |
Poland |
31 |
| 6031 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2018 |
Standard Therapy |
Poland |
37 |
| 6032 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2018 |
Standard Therapy |
Poland |
16 |
| 6033 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2018 |
Standard Therapy |
Poland |
48 |
| 6034 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2018 |
Standard Therapy |
Poland |
52 |
| 6035 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2018 |
Standard Therapy |
Poland |
1 |
| 6036 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2018 |
Standard Therapy |
Poland |
1 |
| 6037 |
Bone Marrow |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
62 |
| 6038 |
Bone Marrow |
Allogeneic |
Other Non-Malignant Disease |
Hematology |
2018 |
Standard Therapy |
Poland |
29 |
| 6039 |
Bone Marrow |
Allogeneic |
Primary Myelofibrosis Grade III |
Hematology |
2018 |
Standard Therapy |
Germany |
73 |
| 6040 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
19 |
| 6041 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
14 |
| 6042 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
27 |
| 6043 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
18 |
| 6044 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
2 |
| 6045 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
20 |
| 6046 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Poland |
6 |
| 6047 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2018 |
Standard Therapy |
Germany |
54 |
| 6048 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2018 |
Standard Therapy |
Poland |
2 |
| 6049 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2018 |
Standard Therapy |
Poland |
1 |
| 6050 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2018 |
Standard Therapy |
Poland |
7 months |
| 6051 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2018 |
Standard Therapy |
Poland |
21 |
| 6052 |
Bone Marrow |
Allogeneic |
T-Cell Leukemia/Lymphoma |
Hematology |
2018 |
Standard Therapy |
Poland |
10 |
| 6053 |
Bone Marrow |
Allogeneic |
Thalassemia Major |
Hematology |
2018 |
Standard Therapy |
Poland |
14 |
| 6054 |
Bone Marrow |
Allogeneic |
Thalassemia Major |
Hematology |
2018 |
Standard Therapy |
Poland |
12 |
| 6055 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
29 |
| 6056 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
63 |
| 6057 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
65 |
| 6058 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
48 |
| 6059 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
50 |
| 6060 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
33 |
| 6061 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
61 |
| 6062 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
42 |
| 6063 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
47 |
| 6064 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
62 |
| 6065 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
50 |
| 6066 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
8 |
| 6067 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
49 |
| 6068 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
59 |
| 6069 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
20 |
| 6070 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
27 |
| 6071 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
1 |
| 6072 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
61 |
| 6073 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
33 |
| 6074 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
33 |
| 6075 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
21 |
| 6076 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
39 |
| 6077 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
50 |
| 6078 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
7 months |
| 6079 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
25 |
| 6080 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
64 |
| 6081 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
36 |
| 6082 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
49 |
| 6083 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
20 |
| 6084 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
44 |
| 6085 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
59 |
| 6086 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
55 |
| 6087 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
30 |
| 6088 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
34 |
| 6089 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
48 |
| 6090 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
40 |
| 6091 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
45 |
| 6092 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
9 |
| 6093 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
8 |
| 6094 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
47 |
| 6095 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Poland |
24 |
| 6096 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
52 |
| 6097 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
43 |
| 6098 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
52 |
| 6099 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
59 |
| 6100 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2018 |
Standard Therapy |
Germany |
24 |